Tracy Neuendorf, DO
Pain Medicine · Youngstown, OHNPI 1275509275
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,103 of the $8,068 with a category attached, or 75.6%. Medtronic accounts for 79.1% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2021 at $3,743 and has fallen 96.6% since, to $129 in 2024.
Across 119 payments — averaging $67.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Collegium Pharmaceutical, Inc.$340
- Tersera Therapeutics LLC$330
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$191
- Nevro Corp.$105
- Amgen$88
- plus $634 from 26 others
What the payments were for
- Speaking & faculty fees$6,10376%
- Travel & lodging$901%
- Food & beverage$1,87623%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(3 entities) | 12 | $6,379 |
| Collegium Pharmaceutical, Inc. | 24 | $340 |
| Tersera Therapeutics LLC | 18 | $330 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $191 |
| Nevro Corp. | 5 | $105 |
| Amgen | 6 | $88 |
| Protega Pharmaceutials Inc | 2 | $72 |
| Kowa Pharmaceuticals America, Inc. | 3 | $54 |
| Daiichi Sankyo Inc. | 2 | $35 |
| Si-bone, Inc. | 2 | $33 |
| Arbor Pharmaceuticals, Inc. | 2 | $33 |
| IBSA Pharma Inc. | 2 | $30 |
| Zyla Life Sciences, Inc. | 2 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Almatica Pharma LLC | 2 | $27 |
| AbbVie(2 entities) | 2 | $27 |
| Hikma Pharmaceuticals USA | 2 | $25 |
| Ultragenyx Pharmaceutical Inc. | 2 | $25 |
| Scilex Pharmaceuticals Inc. | 2 | $24 |
| Alkermes, Inc. | 1 | $22 |
| Bioventus LLC | 1 | $21 |
| Fidia Pharma USA Inc. | 2 | $19 |
| Painteq LLC | 1 | $16 |
| Novartis | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| MDD US Operations, LLC | 1 | $13 |
| Boston Scientific | 1 | $13 |
| Indivior Inc. | 1 | $13 |
| Pfizer | 1 | $12 |
| Orexo US, Inc. | 1 | $11 |
| Elutia, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADAPTIVESTIM$2,695
How this compares
$8,068 in reported general payments places this provider in the 75th percentile of 245 pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 68 | $1,672 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $605 |
| Gabapentin | 33 | $485 |
| Cephalexin | 36 | $434 |
| Oxycodone Hcl | 27 | $378 |
| Cyclobenzaprine Hcl | 22 | $280 |
| Pregabalin | 20 | $249 |
| Tizanidine Hcl | 15 | $178 |
| Tramadol Hcl | 14 | $131 |
| Baclofen | 12 | $127 |
| Mupirocin | 21 | $121 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Youngstown
- Alexander EscobarToledo$638K
- Nagy MekhailCleveland$511K
- Henry VuceticWilloughby$509K
- Tammy DannDayton$431K
- Michael DankoLoveland$381K
- Jonathan SilvermanDayton$234K
- Tristan WeaverColumbus$202K
- Robert BolashCleveland$154K
- Dmitri SouzaCuyahoga Falls$61K
- Aman UpadhyayCleveland$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.